Plus Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Plus Therapeutics Inc 's ROA in the second quarter of 2026?
Plus Therapeutics Inc recorded a cumulative net loss of $-26 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -151.81%.

However, within the Healthcare sector 902 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 4562 to 5114.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	35.56 %	63.5 %	146.12 %	167.56 %	-7.69 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-26	-12	-22	-21	-19
Return On Assets (TTM)	-151.81 %	-73.36 %	-156 %	-172.51 %	-211.31 %
PSTV's Total Ranking	# 5114	# 4562	# 4686	# 4822	# 5441
Total Assets (TTM) in million	14	20	16	19	10
Seq. Total Assets Change	-28.83 %	20.75 %	-12.56 %	80.39 %	-14.15 %
Seq. Net Income Change	-	-	-	-	-

PSTV's 5 Years Annual ROA >> Back to PSTV Management Effectiveness >> Compare PSTV ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 200
Sector	# 903
Overall	# 5060

Return On Assets Statistics
High	Average	Low
-5.33 %	-84.56 %	-294.13 %
(Mar 31 2016)		(Mar 31 2025)

Financial Statements
Plus Therapeutics Inc 's Assets	$ 14 million	PSTV's Balance sheet
Plus Therapeutics Inc 's Income	$ -9 million	Quarterly PSTV's Income Statement
PSTV's Income by Division		See PSTV's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	146.12 %	-41.75 %	-52.29 %	8.58 %	81.59 %
Total Assets in million	16	7	11	24	22
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-22	-13	-13	-20	-13
Annual Return On Assets	-137.13 %	-195.66 %	-116.93 %	-84.95 %	-60.96 %

PSTV's 5 Years Annual ROA >> Back to PSTV Management Effectiveness >> Compare PSTV ROA to its Competitors

More Return On Assets Ratios
PSTV's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PSTV's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PSTV's Competitors
Subscribers only: Roa for Plus Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for PSTV's Customers

You may also want to know
PSTV's Roi	PSTV's Inventory Turnover Ratio	PSTV's Growth Rates	PSTV's Dividend Comparisons
	PSTV's Profitability Ratios	PSTV's Asset Turnover Ratio	PSTV's Dividend Growth
PSTV's Roe	PSTV's Valuation Ratios	PSTV's Financial Strength Ratios	PSTV's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-08-16T08:50:50+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.